Skip to main content
. 2022 Feb 9;11(1):2019466. doi: 10.1080/2162402X.2021.2019466

Table 1.

Patient sets and baseline characteristics of all patients included in this study

Variable Total
(n = 35)
Flow cytometric T cell analysis set
(n = 18)
RNAseq set
(n = 8)
Gender
Male
Female
26
9
15
3
6
2
Histology
Adenocarcinoma
Squamous
17
18
8
10
5
3
Smoking history
Current
Former
Never
Unknown
18
29
2
5
12
15
1
2
6
8
0
Pack years
≥50
<50
Unknown
15
15
5
9
7
2
5
3
Tumor Grade
G1
G2
G3
Unknown
1
18
11
5
1
8
6
3
4
3
1
Tumor stage
IIA
IIIIA
IB
IIB
IIIB
IV
Unknown
3
14
6
8
1
2
1
3
8
1
4
0
1
1
3
1
3
1
Tumor size (cm)
<4 cm
≥4 cm
12
23
6
12
3
5
COPD 4 3 1
Prior Tx
Chemotherapy
11 7 1
Survival
Alive
Dead
24
11
10
8
4
4